$RGBP Zander Therapeutics Inc. is the exclusive l
Post# of 98046
(Total Views: 235)
Posted On: 03/02/2017 12:03:45 PM
$RGBP Zander Therapeutics Inc. is the exclusive licensee for veterinary applications of Regen BioPharma Inc. (RGBP) (RGBPP) intellectual property and technology relating to NR2F6. NR2F6 is a molecular switch known as an 'orphan nuclear receptor', which controls genes associated with the immune response. Zander Therapeutics is solely focused on veterinary applications.
https://finance.yahoo.com/news/regen-biopharm...00603.html
https://finance.yahoo.com/news/regen-biopharm...00603.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼